Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
sumatriptan
|
| gptkbp:ATCCode |
N02CC01
|
| gptkbp:contraindication |
gptkb:basilar_migraine
gptkb:hemiplegic_migraine ischemic heart disease uncontrolled hypertension peripheral vascular disease history of stroke |
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:drugClass |
triptan
|
| gptkbp:FDAapprovalYear |
2015
|
| gptkbp:form |
nasal powder
|
| https://www.w3.org/2000/01/rdf-schema#label |
ONZETRA Xsail
|
| gptkbp:indication |
migraine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
Impel NeuroPharma
|
| gptkbp:mechanismOfAction |
serotonin 5-HT1B/1D receptor agonist
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionStatus |
Rx only
|
| gptkbp:routeOfAdministration |
intranasal
|
| gptkbp:sideEffect |
nausea
vomiting nasal discomfort abnormal taste |
| gptkbp:bfsParent |
gptkb:OptiNose
|
| gptkbp:bfsLayer |
7
|